We are excited to announce a groundbreaking partnership with The Mark Foundation for Cancer Research (MFCR). Together, we are launching a global initiative to fund innovative research projects exploring the complex connection between aging and cancer.

Later this month we will be inviting leading scientists from across the globe to submit novel research proposals that are focused in this field.

Selected projects will receive $500,000 in funding over three years, during which time, SWCRF along with MFCR, plan to invest up to $11 million into specific aging-cancer research.

This significant financial commitment underscores our organization’s shared dedication to advancing pioneering science and tackling cancer’s toughest challenges.

Since, aging is the leading cause of cancer development and progression, as well as poses many treatment challenges, this area of research is crucial to combating the global rise in cancer incidence and improving outcomes for all cancer patients.

These research projects will address critical topics such as:

• Identifying actionable biomarkers that predict aging/cancer risk.
• Understanding how aging impacts tumor growth.
• Exploring the role of the aging immune system in cancer treatment.
• Investigating how metabolism and genetics contribute to cancer development.
• Studying how premature aging increases cancer risk for younger adults.

By supporting this program, SWCRF is further cementing its international leadership in addressing one of the most urgent challenges in cancer prevention and treatment today.

Your continuing support makes this possible. Please consider donating today to help fund this and other vital research programs.

Let’s work together to end cancer in our lifetime.

Warm regards,

Samuel Waxman, MD

Founder and CEO

William T. Sullivan

Executive Director

CLINICAL BREAKTHROUGHS

New Treatment for Liver Cancer Slows Progression and

Improves Survival

A recent study by SWCRF-investigator, Dr. Josep Llovet (Icahn School of Medicine at Mount Sinai), and colleagues has discovered a new treatment approach for unresectable,

non-metastatic hepatocellular carcinoma (HCC)—a form of liver cancer that cannot be surgically removed and has not yet spread to other parts of the body. Around 45,000 cases of HCC are diagnosed yearly in the US and about 1M globally.

According to their research, published in The Lancet (January 2025), combining transarterial chemoembolisation (TACE) with the drugs lenvatinib (a targeted therapy) and pembrolizumab (an immunotherapy) significantly improved patient outcomes compared to the placebo group.

Specifically, patients receiving this combination therapy experienced slower tumor progression and a trend towards overall higher survival rates. Additionally, the drug combination was well-tolerated, with manageable side effects, supporting its potential as a viable treatment option in patients with intermediate HCC.

“SWCRF has been instrumental in supporting the development of the HCC program at Mount Sinai since 2004. Their commitment to funding innovative cancer research has allowed us to make these significant strides in understanding and treating this devastating disease. This breakthrough would not have been possible without their continued support”, said Dr Josep M Llovet, Professor of Medicine and Director of the Liver Cancer Program at the Ichan School of Medicine.

This remarkable improvement marks the first clinical breakthrough in treating this challenging and often fatal form of cancer in more than 20 years.

SAVE-THE-DATE

SAVE-THE-DATE

THE WAXMAN LUNCHEON

We’re thrilled to announce an exclusive partnership with Seabourn Cruises.

When you book any Seabourn cruise (excluding World Cruise or Grand Cruise), 10% of your fare will be donated directly to the Samuel Waxman Cancer Research Foundation.

This is your chance to indulge in a luxury cruise experience, while supporting cancer research in a meaningful way.

Select from an array of breathtaking itineraries on eligible voyages through December 25, 2025. Choose from voyages to the Amazon, Arctic, Australia & New Zealand, Asia, the Caribbean, the Mediterranean, and more.

To reserve your next adventure, contact our dedicated Seabourn consultant:

Roseanne Bishop, Personal Cruise Consultant

800.929.4747 Ext. 29398

 RBishop@Seabourn.com

**Offer Code: WAXMANCRI**

Prefer to book online or through your travel agent? Simply provide the same offer codes.

Join us in this extraordinary journey – a chance to explore the world and make a positive impact in the fight against cancer. Book today!

Samuel Waxman Cancer Research Foundation | Website | Telephone 212-867-4502

The post SWCRF and The Mark Foundation Partner to Launch $500,000 Aging and Cancer Research Grants appeared first on Good News!.

The 25th Annual Collaborating for a Cure Gala, one of New York City’s favorite charity events celebrated its silver anniversary at Cipriani Wall Street. The “fun-raiser as opposed to fundraiser” as described by Michael Nierenberg raised more than $6 million towards the goal of funding the next five years of crucial SWCRF cancer research programs such as the Partnership for Aging and Cancer Research Program, the SWCRF Institute Without WallsTM, and the Women’s Cancer Research Program.

Following a cocktail reception across the street, guests made their way to the main dining room where emcee, CBS’s Chris Wragge, welcomed the more than 700 guests, introduced the evening’s honorees, and highlighted many of the Foundation’s groundbreaking achievements over the past 50 years. “Tonight, we have a great program to celebrate two giants in the fight against cancer”, said Wragge.

Upon receiving the Vision and Leadership Award, SWCRF Board Chairman Michael Nierenberg commented, “The real honorees are Dr. Waxman and the great heroes like him who treat and cure cancer every day.”

Founder and CEO Dr. Samuel Waxman, who received the well-deserved and long-overdue Lifetime Achievement Award, spoke to his vision (goal) for a future in which cancer does not have to be a disease associated with aging. “The incidence of cancer is increasing, in part, as a by-product of improvements we are making in human longevity,” said Dr. Waxman. “But through our collaborative research programs, we can flatten this curve. I am thrilled to be a part of many amazing breakthroughs that have occurred in cancer research – with more to come.”

Special guest, author and breast cancer survivor, Musa Mayer, shared why she has been a longtime supporter of SWCRF and very generously offered a $1 million match for all donations made during the gala. “I will be celebrating my 80th birthday soon thanks to the work of this foundation and Dr. Samuel Waxman,” said Mayer.

As in previous years, the Collaborating for a Cure Gala included a live auction during the night’s festivities, including a meet and greet with MT. JOY, culinary experiences at the Cipriani Vault, il Buco Vita, and New York Vintners, and a Palm Bay Italian Winery experience (in Tuscany) to name a few. There was also a raffle for a private 7-day Bahamas cruise aboard an 82-foot, hybrid-powered, luxury yacht.

Notable attendees include SWCRF Board Chairman Michael Nierenberg, Founder and CEO Dr. Samuel Waxman, Gala Event Chairs, Spencer Waxman, Nicholas Santoro, Baron Silverstein, Marc Taub and Gala MC, Chris Wragge, Elin Nierenberg, Marion Waxman, Sandra Dugoff, Julie Waxman, Eliz Waxman, Jack Waxman, Sophia Bergan, Mario Pecoraro, Chris Arlotta, Mark D. Friedman, Jeremy Hoffman, Sara Waxman, Bettina Waxman, Scott Waxman, Bryan Griffin, Katya Tolstova, Nadja Sayej, William T. Sullivan, Erica Fineberg. Robin Lathrop, MT. JOY.

Known for its history of top-notch live performances, this year’s gala featured a live concert by MT. JOY.

For more information, visit www.waxmancancer.org/gala.

For selected high-resolutions images, visit: https://bit.ly/3XbltYB

(Photo credits: Jared Siskin PMC/Getty Images)

To view the Full Gallery of Images (Patrick McMullen): https://bit.ly/3OfqN9r

To view the Full Gallery of Images (Getty Images): https://bit.ly/3OikJwC

About The Samuel Waxman Cancer Research Foundation (SWCRF):

The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research and its mission is to eradicate cancer by funding cutting-edge research that identifies and corrects abnormal gene function that causes cancer and develops minimally toxic treatments for patients. Through the Foundation’s collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the Samuel Waxman Cancer Research Foundation has awarded more than $100 million to support the work of more than 200 researchers across the globe. For more information about the SWCRF research, visit www.waxmancancer.org.

Facebook: WaxmanCancer https://www.facebook.com/WaxmanCancer

Instagram: @waxmancancer https://www.instagram.com/waxmancancer/

Twitter: @waxmancancer https://twitter.com/WaxmanCancer

PRESS CONTACT (SWCRF):

Norah Lawlor | Lawlor Media Group | www.lawlormediagroup.com

Norah@lawlormediagroup.com | Tel: (212) 967-6900

I: lawlormedia | T: @LawlorMedia | F: LawlorMediaGroup

Samuel Waxman, M.D., Marion Waxman (Photo Credit: Jared Siskin PMC/Getty Images)

Chris Wragge, Michael Nierenberg (Photo Credit: Jared Siskin PMC/Getty Images)

Gala MC Chris Wragge (Photo Credit: Jared Siskin PMC/Getty Images)

Bryan Griffin (Photo Credit: Jared Siskin PMC/Getty Images)

Katya Tolstova (Photo Credit: Jared Siskin PMC/Getty Images)

Nadja Sayej (Photo Credit: Jared Siskin PMC/Getty Images)

Lawlor Media Group, inc.

434 West 33rd Street

7th Floor

New York, NY

10001

United States of America

T: 212.967.6900 C: 917.774.1000

www.lawlormediagroup.com

This message is confidential. It may also be privileged or otherwise protected by work product immunity or other legal rules. If you have received it by mistake, please let us know by e-mail reply and delete it from your system; you may not copy this message or disclose its contents to anyone. The integrity and security of this message cannot be guaranteed on the Internet.

#samwaxman #samuelwaxman #cancer #curegala #newyorkcity #ny #nyc #samuelwaxmancancerresearchfoundation #swcrf #cipriani #wallstreet

The post Samuel Waxman Cancer Research Foundation 25th Annual Collaborating for a Cure Gala appeared first on Good News!.

Join Katlean de Monchy, MUSES Founder and creator of MUSES LIVE,
to a private one-hour virtual celebration to support the

Samuel Waxman Cancer Research Foundation

Thursday, June 25
1-2 pm EDT

Acclaimed fashion designer Kobi Halperin will present a curated collection available for purchase. Enjoy additional special guest appearances.

20/20 in 2020
Shoppers receive 20% in savings and 20% of proceeds will be donated to the SWCRF in support of research.

Choose from exclusive experiences curated by Kobi Halperin available during the live show only! One-hundred percent of proceeds from experiences support the SWCRF research programs!

RSVP NOW

M BE INSPIRED
MUSES LIVEMUSES Founder,

Katlean de Monchyinvites you to experience

M LIVE

Thursday, June 251pm – 2pm

a private one hour virtual celebration to benefit the

xqpresented by KOBI HALPERIN

Join Samuel Waxman,

M.D. and Muses Pamela Morgan & Marion Waxman

to ENGAGE, LEARN and SHOP.

Special guest appearance by acclaimed fashion designer Kobi Halperin, who will be presenting a curated collection expressly for purchase to benefit the SWCRF.

Shop 20/20 in 2020:20% savings for you and 20% of proceeds will be donated to the SWCRFRSVP NOW Required for access to MUSES LIVE

https://nextpert.us4.list-manage.com/track/click?u=dbdb6b9d5e65d31750e13efdf&id=1803a6ace0&e=cc51c9fd26

The post Samuel Waxman Cancer Research Foundation appeared first on Good News!.